BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24947616)

  • 1. Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients.
    Cho EC; Kuo ML; Liu X; Yang L; Hsieh YC; Wang J; Cheng Y; Yen Y
    Oncotarget; 2014 Jul; 5(13):4834-44. PubMed ID: 24947616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RRM2B-Mediated Regulation of Mitochondrial Activity and Inflammation under Oxidative Stress.
    Cho EC; Kuo ML; Cheng JH; Cheng YC; Hsieh YC; Liu YR; Hsieh RH; Yen Y
    Mediators Inflamm; 2015; 2015():287345. PubMed ID: 26089597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.
    Foskolou IP; Jorgensen C; Leszczynska KB; Olcina MM; Tarhonskaya H; Haisma B; D'Angiolella V; Myers WK; Domene C; Flashman E; Hammond EM
    Mol Cell; 2017 Apr; 66(2):206-220.e9. PubMed ID: 28416140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RRM2B suppresses activation of the oxidative stress pathway and is up-regulated by p53 during senescence.
    Kuo ML; Sy AJ; Xue L; Chi M; Lee MT; Yen T; Chiang MI; Chang L; Chu P; Yen Y
    Sci Rep; 2012; 2():822. PubMed ID: 23139867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
    Qi W; Weber CR; Wasland K; Savkovic SD
    BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.
    Chung YM; Park SH; Tsai WB; Wang SY; Ikeda MA; Berek JS; Chen DJ; Hu MC
    Nat Commun; 2012; 3():1000. PubMed ID: 22893124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
    Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.
    Jørgensen CL; Ejlertsen B; Bjerre KD; Balslev E; Nielsen DL; Nielsen KV
    BMC Cancer; 2013 Nov; 13():541. PubMed ID: 24215511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
    Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
    Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
    Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
    Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
    Renault VM; Thekkat PU; Hoang KL; White JL; Brady CA; Kenzelmann Broz D; Venturelli OS; Johnson TM; Oskoui PR; Xuan Z; Santo EE; Zhang MQ; Vogel H; Attardi LD; Brunet A
    Oncogene; 2011 Jul; 30(29):3207-21. PubMed ID: 21423206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.
    Kuo ML; Lee MB; Tang M; den Besten W; Hu S; Sweredoski MJ; Hess S; Chou CM; Changou CA; Su M; Jia W; Su L; Yen Y
    Sci Rep; 2016 Jan; 6():18846. PubMed ID: 26733354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer.
    Yin X; Jiang K; Zhou Z; Yu H; Yan D; He X; Yan S
    Oxid Med Cell Longev; 2023; 2023():3878796. PubMed ID: 36713030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.
    Geiger K; Hagenbuchner J; Rupp M; Fiegl H; Sergi C; Meister B; Kiechl-Kohlendorfer U; Müller T; Ausserlechner MJ; Obexer P
    Mol Biol Cell; 2012 Jun; 23(11):2226-34. PubMed ID: 22493319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.
    Kurinna S; Stratton SA; Tsai WW; Akdemir KC; Gu W; Singh P; Goode T; Darlington GJ; Barton MC
    Hepatology; 2010 Sep; 52(3):1023-32. PubMed ID: 20564353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
    Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
    Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer.
    Liu X; Lai L; Wang X; Xue L; Leora S; Wu J; Hu S; Zhang K; Kuo ML; Zhou L; Zhang H; Wang Y; Wang Y; Zhou B; Nelson RA; Zheng S; Zhang S; Chu P; Yen Y
    Cancer Res; 2011 May; 71(9):3202-13. PubMed ID: 21415168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.
    Bollinger LM; Witczak CA; Houmard JA; Brault JJ
    Am J Physiol Cell Physiol; 2014 Aug; 307(3):C278-87. PubMed ID: 24920680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
    Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
    Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.